Avanos Medical, Inc. (AVNS) Financials

AVNS Assets vs Liabilities

DateAssetsLiabilities
2024-03-31 1.7 billion 433.4 million
2023-12-31 1.7 billion 456.1 million
2023-09-30 1.7 billion 502.8 million
2023-06-30 1.7 billion 431.9 million

AVNS Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-03-31 -4.1 million 3.6 million
2023-12-31 6.8 million 4.0 million
2023-09-30 25.2 million 3.9 million
2023-06-30 -6.6 million 3.9 million

AVNS Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2024-03-31 -900000
2023-12-31 11.0 million
2023-09-30 -3.7 million
2023-06-30 -68.1 million

AVNS Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-03-31 75.8 million - 38.1 million
2023-12-31 87.7 million - 41.1 million
2023-09-30 107.1 million - 42.2 million
2023-06-30 81.8 million - 44.4 million

AVNS Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-03-31 46.1 million
2023-12-31 46.6 million
2023-09-30 46.8 million
2023-06-30 46.8 million

AVNS Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-03-31 4.1 million 7.0 million 83.6 million -
2023-12-31 5.9 million 6.8 million 74.5 million -
2023-09-30 3.9 million 6.1 million 78.7 million -
2023-06-30 4.0 million 6.8 million 93.0 million -

AVNS Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-03-31 166.1 million 71.3 million
2023-12-31 173.3 million 75.9 million
2023-09-30 171.3 million 75.8 million
2023-06-30 169.4 million 71.6 million

AVNS

Price: $19.73

52 week price:
17.24
31.31

Earnings Per Share: -0.21 USD

P/E Ratio: 52.57

Exchange: NYQ

Sector: Healthcare

Industry: Medical Devices

Volume: 284800

Market Capitalization: 903.4 million

Links: